Ascendis Pharma A-S (ASND) had the highest return in February 2017 by a US stock with a market cap of $10B+, returning 37.9%.
| ASSET | MONTH | % RETURN |
|---|---|---|
Ascendis Pharma A-S (ASND) | February 2017 | 37.86% |
Advanced Micro Devices (AMD) | February 2017 | 32.66% |
Alnylam Pharmaceuticals (ALNY) | February 2017 | 28.87% |
Corcept Therapeutics (CORT) | February 2017 | 28.06% |
Arista Networks (ANET) | February 2017 | 26.36% |
Howmet Aerospace (HWM) | February 2017 | 23.72% |
Block (XYZ) | February 2017 | 19.53% |
Lumentum (LITE) | February 2017 | 19.22% |
Bunge Global (BG) | February 2017 | 19.15% |
NetEase (NTES) | February 2017 | 18.98% |
Cadence Design Systems (CDNS) | February 2017 | 18.71% |
IDEXX Laboratories (IDXX) | February 2017 | 18.42% |
Exelixis (EXEL) | February 2017 | 18.1% |
TransUnion (TRU) | February 2017 | 17.49% |
Hasbro (HAS) | February 2017 | 17.45% |
Transdigm (TDG) | February 2017 | 17.07% |
CBRE Group Inc Class A (CBRE) | February 2017 | 16.75% |
Unilever PLC ADR (UL) | February 2017 | 16.71% |
Ameriprise Financial (AMP) | February 2017 | 16.46% |
Bristol-Myers Squibb (BMY) | February 2017 | 15.43% |
First Solar (FSLR) | February 2017 | 15.25% |
HP (HPQ) | February 2017 | 14.88% |
Ternium SA ADR (TX) | February 2017 | 14.76% |
Corpay (CPAY) | February 2017 | 14.75% |
HubSpot (HUBS) | February 2017 | 14.64% |